Qualigen Partners with BitGo for $30 M Crypto Treasury Allocation
Qualigen Therapeutics (NASDAQ: QLGN) has entered a strategic partnership with BitGo, committing $30 million to a multi-asset “C10” treasury strategy that invests in a market-cap-weighted basket of the world’s top 10 crypto assets (excluding stablecoins).
Through BitGo’s institutional infrastructure—including an OTC desk, regulated cold custody, and deep liquidity access—Qualigen aims to establish a “digital-first” treasury model and diversify its holdings into leading cryptocurrencies.
This move reflects broader corporate interest in crypto as a treasury tool and may signal increasing institutional confidence in digital-asset allocation strategies.